NASDAQ:LEVB

Level Brands (LEVB) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$5.31
$6.17
50-Day Range
$6.08
$6.08
52-Week Range
$2.54
$8.48
Volume
604,917 shs
Average Volume
136,520 shs
Market Capitalization
$61.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Level Brands

Level Brands, Inc. operates as a branding and marketing company. It operates through three business segments: Professional Products, Licensing, and Entertainment. The Professional Products segment produces and markets hair care and beauty products. This segment offers silkening shampoo and conditioner under the Flaunt name; spray gel under the Linger; spray on conditioner under the Luxe name; firm hold finishing spray under the Fierce name; all in 1 cleansing and conditioning product under the Lavish name; hair rescue treatment product; blow out styling primer enhanced with marine botanicals under the Sway name; hair spray under the Valor name; thermal protectant under the Fever name; shampoo and conditioner under the Rewind name; and dry shampoo under the Stay Dirty name. The Licensing division designs lifestyle brands through licensing of selected products and categories, such as grooming, personal care, cologne, accessories, jewelry, and apparels primarily needs of the men. The Entertainment division produces and markets various entertainment experiences, including recordings, film, TV, Web and live event, and entertainment experiences; and provides brand management services, such as development and marketing, brand strategy, and distribution. The company was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

LEVB Stock News Headlines

One trade. One ticker. One week.
Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week?
What Does It Mean To Be A ‘Human’ Brand?
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Level Up Your Loungewear
The Death Of Brand Loyalty
Bring Back The 'Love Brands'
Personal Brand Leadership
Level up in life by establishing a personal brand
See More Headlines
Receive LEVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Level Brands and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2018
Today
4/25/2024

Industry, Sector and Symbol

Industry
Marketing Services
Sub-Industry
N/A
Current Symbol
NASDAQ:LEVB
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$61.83 million
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Martin A Sumichrast (Age 50)
    Chairman of the Board, CEO & Pres
  • Mr. Mark S. Elliott (Age 57)
    CFO & COO
  • Ms. Kathy Ireland
    Chief Creative Officer

LEVB Stock Analysis - Frequently Asked Questions

How were Level Brands' earnings last quarter?

Level Brands (NASDAQ:LEVB) announced its earnings results on Tuesday, August, 14th. The company reported $0.03 earnings per share (EPS) for the quarter. The company had revenue of $3.20 million for the quarter.

What other stocks do shareholders of Level Brands own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Level Brands investors own include Corbus Pharmaceuticals (CRBP), CV Sciences (CVSI), NewAge (NBEV), Zynerba Pharmaceuticals (ZYNE), Curaleaf (CURLF), Heron Therapeutics (HRTX), Inovio Pharmaceuticals (INO) and KushCo (KSHB).

This page (NASDAQ:LEVB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners